Pharmacogenetics of P450 CYP3A4 and CYP3A5 in the Tunisian population: Clinical application with tacrolimus

Abstract

Human cytochrome P450 (CYP), particularly CYP3A4 and CYP3A5 is mainly responsible for the metabolism of several drugs including Tacrolimus. Significant interracial/interethnic variation in the expression and function of CYP3A5... [ view full abstract ]

Authors

  1. Ibtissem Hannachi (Pharmacology Department, University Hospital, Monastir, Tunisia. Faculty of Medicine, University of Monastir, Tunisia.)
  2. Zohra CHADLI (Pharmacology Department, University Hospital, Monastir, Tunisia. Faculty of Medicine, University of Monastir, Tunisia.)
  3. Emna Kerkeni (Pharmacology Department, University Hospital, Monastir, Tunisia. Faculty of Medicine, University of Monastir, Tunisia.)
  4. Amel Chaabane (Pharmacology Department, University Hospital, Monastir, Tunisia. Faculty of Medicine, University of Monastir, Tunisia.)
  5. Nadia Ben Fredj (Pharmacology Department, University Hospital, Monastir, Tunisia. Faculty of Medicine, University of Monastir, Tunisia.)
  6. Naceur Boughattas (Pharmacology Department, Faculty of Medicine, University of Monastir, Tunisia.)
  7. Karim Aouam (Pharmacology Department, University Hospital, Monastir, Tunisia. Faculty of Medicine, University of Monastir, Tunisia.)

Topic Area

Personalized therapies (cancer, immunology, infectious diseases, clinical case studies, et

Session

PS1 » Poster Session (14:00 - Monday, 25th June, Main hall)

Presentation Files

The presenter has not uploaded any presentation files.